An update on the pharmacology of serotoninergic appetite-suppressive drugs

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

D-Fenfluramine, fluoxetine and sertraline are considered to be serotoninergic appetite-suppressive drugs. These three agents have been compared in fasted mice, rats and guinea pigs for their activity as food intake inhibitors. D-Fenfluramine is the most effective drug in the three animal species followed by fluoxetine and then sertraline. All three compounds are metabolized to N-dealkylated metabolites which accumulate in the brain and are themselves effective in reducing food intake. At anorectic doses the brain levels of the drugs and their metabolites are compatible with the concentrations able to block serotonin (5-HT) uptake and to release brain 5-HT from brain synaptosomes. However only the anorectic activity of D-fenfluramine is antagonized by the previous administration of 5-HT antagonists. These results cast some doubts on the role of brain 5-HT in explaining the anorectic activity of fluoxetine and sertraline.

Original languageEnglish
JournalInternational Journal of Obesity
Volume16
Issue numberSUPPL. 4
Publication statusPublished - 1992

Fingerprint

Appetite
pharmacology
appetite
serotonin
fenfluramine
Fenfluramine
Sertraline
Appetite Depressants
Pharmacology
Fluoxetine
Serotonin
brain
drugs
Brain
Pharmaceutical Preparations
food intake
Eating
synaptosomes
metabolites
Serotonin Antagonists

Keywords

  • Anorexia
  • D-fenfluramine
  • Fluoxetine
  • Food intake
  • Serotonin receptors
  • Serotonin uptake
  • Serotoninergic drugs
  • Sertraline

ASJC Scopus subject areas

  • Food Science
  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Public Health, Environmental and Occupational Health

Cite this

An update on the pharmacology of serotoninergic appetite-suppressive drugs. / Garattini, S.

In: International Journal of Obesity, Vol. 16, No. SUPPL. 4, 1992.

Research output: Contribution to journalArticle

@article{cfd44c2d94a945c69ed6c8e207bb9553,
title = "An update on the pharmacology of serotoninergic appetite-suppressive drugs",
abstract = "D-Fenfluramine, fluoxetine and sertraline are considered to be serotoninergic appetite-suppressive drugs. These three agents have been compared in fasted mice, rats and guinea pigs for their activity as food intake inhibitors. D-Fenfluramine is the most effective drug in the three animal species followed by fluoxetine and then sertraline. All three compounds are metabolized to N-dealkylated metabolites which accumulate in the brain and are themselves effective in reducing food intake. At anorectic doses the brain levels of the drugs and their metabolites are compatible with the concentrations able to block serotonin (5-HT) uptake and to release brain 5-HT from brain synaptosomes. However only the anorectic activity of D-fenfluramine is antagonized by the previous administration of 5-HT antagonists. These results cast some doubts on the role of brain 5-HT in explaining the anorectic activity of fluoxetine and sertraline.",
keywords = "Anorexia, D-fenfluramine, Fluoxetine, Food intake, Serotonin receptors, Serotonin uptake, Serotoninergic drugs, Sertraline",
author = "S. Garattini",
year = "1992",
language = "English",
volume = "16",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "SUPPL. 4",

}

TY - JOUR

T1 - An update on the pharmacology of serotoninergic appetite-suppressive drugs

AU - Garattini, S.

PY - 1992

Y1 - 1992

N2 - D-Fenfluramine, fluoxetine and sertraline are considered to be serotoninergic appetite-suppressive drugs. These three agents have been compared in fasted mice, rats and guinea pigs for their activity as food intake inhibitors. D-Fenfluramine is the most effective drug in the three animal species followed by fluoxetine and then sertraline. All three compounds are metabolized to N-dealkylated metabolites which accumulate in the brain and are themselves effective in reducing food intake. At anorectic doses the brain levels of the drugs and their metabolites are compatible with the concentrations able to block serotonin (5-HT) uptake and to release brain 5-HT from brain synaptosomes. However only the anorectic activity of D-fenfluramine is antagonized by the previous administration of 5-HT antagonists. These results cast some doubts on the role of brain 5-HT in explaining the anorectic activity of fluoxetine and sertraline.

AB - D-Fenfluramine, fluoxetine and sertraline are considered to be serotoninergic appetite-suppressive drugs. These three agents have been compared in fasted mice, rats and guinea pigs for their activity as food intake inhibitors. D-Fenfluramine is the most effective drug in the three animal species followed by fluoxetine and then sertraline. All three compounds are metabolized to N-dealkylated metabolites which accumulate in the brain and are themselves effective in reducing food intake. At anorectic doses the brain levels of the drugs and their metabolites are compatible with the concentrations able to block serotonin (5-HT) uptake and to release brain 5-HT from brain synaptosomes. However only the anorectic activity of D-fenfluramine is antagonized by the previous administration of 5-HT antagonists. These results cast some doubts on the role of brain 5-HT in explaining the anorectic activity of fluoxetine and sertraline.

KW - Anorexia

KW - D-fenfluramine

KW - Fluoxetine

KW - Food intake

KW - Serotonin receptors

KW - Serotonin uptake

KW - Serotoninergic drugs

KW - Sertraline

UR - http://www.scopus.com/inward/record.url?scp=0027076012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027076012&partnerID=8YFLogxK

M3 - Article

VL - 16

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - SUPPL. 4

ER -